Clinical Trial Update: Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System [NA]

View source ↗

Summary

A completed clinical trial evaluated the Low Glucose Suspend feature of the MiniMed Paradigm X54 insulin pump in people with Type 1 Diabetes Mellitus. Results f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• MiniMed Paradigm X54 System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2017-03-30